Rothschild & Co Asset Management US’s Protagonist Therapeutics PTGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$1.67M Sell
2022
Q3
$1.3M Sell
2022
Q2
$2.9M Sell
2022
Q1
$8.98M Sell
2021
Q4
$16.8M Buy
2021
Q3
$3.85M Sell
2021
Q2
$17.4M Sell
2021
Q1
$11.2M Buy